I am a board-certified medical oncologist with training and experience in Genitourinary Oncology. I am actively involved in diagnosis, treatment, and care of patients with urothelial carcinoma, renal cell carcinoma and prostate cancer. I also have a strong background in new drug development and designing clinical trials. My focus is in developing clinical trials, translational research and develop prognostic and predictive models in urothelial carcinoma assessing response to novel targeted therapy and immunotherapy regimens. I have been the principal investigator of multiple trials, including investigator-initiated, investigating safety and efficacy of different immune check point inhibitor combinations, targeted therapies, and new investigational compounds.